Truist Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Sell |
15,861
-5,213
| -25% | -$432K | ﹤0.01% | 1461 |
|
|
2025
Q1 | $1.71M | Sell |
21,074
-22,826
| -52% | -$1.85M | ﹤0.01% | 1292 |
|
|
2024
Q4 | $3.95M | Buy |
43,900
+9,746
| +29% | +$878K | 0.01% | 929 |
|
|
2024
Q3 | $3.37M | Buy |
34,154
+1,381
| +4% | +$136K | 0.01% | 991 |
|
|
2024
Q2 | $3.04M | Buy |
32,773
+252
| +0.8% | +$23.4K | ﹤0.01% | 1075 |
|
|
2024
Q1 | $3.09M | Sell |
32,521
-88
| -0.3% | -$8.35K | ﹤0.01% | 1081 |
|
|
2023
Q4 | $2.91M | Sell |
32,609
-6,625
| -17% | -$592K | ﹤0.01% | 1078 |
|
|
2023
Q3 | $2.86M | Sell |
39,234
-185
| -0.5% | -$13.5K | ﹤0.01% | 1061 |
|
|
2023
Q2 | $3.28M | Sell |
39,419
-9,837
| -20% | -$818K | 0.01% | 1016 |
|
|
2023
Q1 | $3.75M | Buy |
49,256
+7,017
| +17% | +$535K | 0.01% | 944 |
|
|
2022
Q4 | $3.51M | Buy |
42,239
+3,499
| +9% | +$290K | 0.01% | 953 |
|
|
2022
Q3 | $3.07M | Sell |
38,740
-28,620
| -42% | -$2.27M | 0.01% | 970 |
|
|
2022
Q2 | $5M | Sell |
67,360
-11,692
| -15% | -$868K | 0.01% | 803 |
|
|
2022
Q1 | $7.11M | Buy |
79,052
+40,703
| +106% | +$3.66M | 0.01% | 756 |
|
|
2021
Q4 | $4.29M | Sell |
38,349
-5,731
| -13% | -$642K | 0.01% | 937 |
|
|
2021
Q3 | $5.54M | Sell |
44,080
-168
| -0.4% | -$21.1K | 0.01% | 837 |
|
|
2021
Q2 | $5.99M | Sell |
44,248
-2,430
| -5% | -$329K | 0.01% | 809 |
|
|
2021
Q1 | $6.33M | Buy |
46,678
+139
| +0.3% | +$18.9K | 0.01% | 757 |
|
|
2020
Q4 | $6.55M | Buy |
46,539
+864
| +2% | +$122K | 0.01% | 732 |
|
|
2020
Q3 | $5.09M | Buy |
45,675
+7,567
| +20% | +$843K | 0.01% | 737 |
|
|
2020
Q2 | $4.27M | Buy |
38,108
+8,108
| +27% | +$908K | 0.01% | 758 |
|
|
2020
Q1 | $2.32M | Buy |
30,000
+11,377
| +61% | +$881K | 0.01% | 920 |
|
|
2019
Q4 | $1.77M | Buy |
+18,623
| New | +$1.77M | ﹤0.01% | 1179 |
|